- Home
- NUVL vs WHR Comparison
NUVL vs WHR Comparison
Compare NUVL & WHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVL
- WHR
- Stock Information
- Founded
- NUVL 2017
- WHR 1911
- Country
- NUVL United States
- WHR United States
- Employees
- NUVL N/A
- WHR N/A
- Industry
- NUVL Biotechnology: Pharmaceutical Preparations
- WHR Consumer Electronics/Appliances
- Sector
- NUVL Health Care
- WHR Consumer Discretionary
- Exchange
- NUVL Nasdaq
- WHR Nasdaq
- Market Cap
- NUVL 5.6B
- WHR 5.2B
- IPO Year
- NUVL 2021
- WHR N/A
- Fundamental
- Price
- NUVL $73.48
- WHR $77.34
- Analyst Decision
- NUVL Strong Buy
- WHR Hold
- Analyst Count
- NUVL 8
- WHR 4
- Target Price
- NUVL $115.50
- WHR $106.00
- AVG Volume (30 Days)
- NUVL 682.1K
- WHR 1.5M
- Earning Date
- NUVL 05-08-2025
- WHR 04-23-2025
- Dividend Yield
- NUVL N/A
- WHR 9.04%
- EPS Growth
- NUVL N/A
- WHR N/A
- EPS
- NUVL N/A
- WHR 0.13
- Revenue
- NUVL N/A
- WHR $15,738,000,000.00
- Revenue This Year
- NUVL N/A
- WHR N/A
- Revenue Next Year
- NUVL N/A
- WHR $0.49
- P/E Ratio
- NUVL N/A
- WHR $611.19
- Revenue Growth
- NUVL N/A
- WHR N/A
- 52 Week Low
- NUVL $55.54
- WHR $75.03
- 52 Week High
- NUVL $113.51
- WHR $135.49
- Technical
- Relative Strength Index (RSI)
- NUVL 54.91
- WHR 35.34
- Support Level
- NUVL $71.60
- WHR $76.27
- Resistance Level
- NUVL $74.28
- WHR $81.77
- Average True Range (ATR)
- NUVL 4.86
- WHR 4.88
- MACD
- NUVL 1.08
- WHR 0.15
- Stochastic Oscillator
- NUVL 95.73
- WHR 19.31
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.
About WHR Whirlpool Corporation
Whirlpool Corp is a manufacturer and marketer of home appliances and related products. Its reportable segments consist of five operating segments, which consist of Domestic Appliances (MDA) North America; MDA Europe, MDA Latin America; MDA Asia; and Small Domestic Appliances (SDA). Product categories include refrigeration, laundry, cooking, and dishwashing. The company has also a portfolio of small domestic appliances, including the KitchenAid stand mixer. The company's international brands include Whirlpool, KitchenAid, Maytag, Consul, and Brastemp, among others.